不同剂量利拉鲁肽治疗肥胖型2型糖尿病的效果观察
2015-10-16章国仁王爱华方幼荣等
章国仁+王爱华+方幼荣+等
[摘要] 目的 探讨不同剂量利拉鲁肽治疗肥胖型2型糖尿病的临床疗效。 方法 选取我院2013年5月~2015年5月收治的88例肥胖型2型糖尿病患者作为研究对象,按随机数字表法分为A、B两组(每组44例),两组患者均应用利拉鲁肽进行治疗,A组的单次给药剂量为1.2 mg,B组为1.8 mg,比较两组患者的治疗效果。 结果 两组患者治疗前的各项糖代谢、脂代谢、CRP及心血管指标比较,差异无统计学意义(P>0.05)。治疗后,两组患者的FPG、2 hPG、BMI、TG、TC、LDL-C、CRP及各项心血管指标均较治疗前显著降低(P<0.05),组间比较差异无统计学意义(P>0.05)。两组的一般低血糖及局部瘙痒、硬结发生率比较差异无统计学意义(P>0.05),A组的一过性腹泻、一过性胃肠道反应发生率均显著低于B组(P<0.05)。 结论 利拉鲁肽治疗肥胖型2型糖尿病具有良好的效果,单次给药剂量1.2 mg的治疗效果与1.8 mg相当,低剂量用药安全性更高。
[关键词] 肥胖型2型糖尿病;利拉鲁肽;给药剂量
[中图分类号] R977.1+5 [文献标识码] A [文章编号] 1674-4721(2015)09(c)-0088-04
Effect observation of different doses of liraglutide in the treatment of obese type 2 diabetes mellitus
ZHANG Guo-ren1 WANG Ai-hua2 FANG You-rong2 JIANG Shi-ting3
1.Department of Pharmacy,Poyang County People′s Hospital in Shangrao City of Jiangxi Province,Poyang 333100,China;2.Department of Nursing,Poyang County People′s Hospital in Shangrao City of Jiangxi Province,Poyang 333100,China;3.Department of Endocrinology,Poyang County People′s Hospital in Shangrao City of Jiangxi Province,Poyang 333100,China
[Abstract] Objective To investigate the clinical efficacy of different doses of liraglutide treat with obese type 2 diabetes. Methods 88 patients with obesity type 2 diabetes from May 2013 to May 2015 in our hospital were divided into group A and group B by the random number table (n=44 cases).All patients were treated with liraglutide,group A single dosage was 1.2 mg,group B was 1.8 mg,therapeutic effect between two groups was compared. Results The glucose metabolism,lipid metabolism,CRP and cardiovascular indicators of group A compared with group B were no significant difference(P>0.05).After treatment,the FPG,2 hPG,BMI,TG,TC,LDL-C,CRP and cardiovascular indices between two groups was significantly lower than before treatment respectively,with statistical differenc(P<0.05);General hypoglycemia,local itching and induration incidence between two groups was not statistically significant (P>0.05),but transient diarrhea,transient gastrointestinal reactions of group A were significantly lower than group B(P<0.05). Conclusion Liraglutide treatment of obesity type 2 diabetes has a good effect,a single dose of 1.2 mg can provide the same effect with 1.8 mg,but low doses of medication is more security.
[Key words] Obese type 2 diabetes;Liraglutide;Dosage
2型糖尿病是临床较为常见的一种终身性代谢紊乱性疾病,肥胖是2型糖尿病的一个主要危险因素,近年来随着人们生活方式的改变,肥胖型2型糖尿病的临床发病率呈逐年上升趋势[1]。对于肥胖型2型糖尿病,应用常规血糖控制药物常难以获得理想的效果。利拉鲁肽是一种酰化胰高血糖素样肽(GLP-1)类似物,其与天然的GLP-1的同源性极高,具有良好的减重、降糖、促胰岛β细胞再生等作用,是国际临床治疗肥胖和糖尿病的常用药物[2]。目前,已有临床实践证实利拉鲁肽治疗肥胖型2型糖尿病具有确切的疗效,但关于利拉鲁肽治疗肥胖型2型糖尿病的最佳给药剂量尚存争议。本研究旨在了解不同剂量利拉鲁肽治疗肥胖型2型糖尿病的临床疗效,找到利拉鲁肽治疗肥胖型2型糖尿病的最佳剂量。 ……
